Standard BioTools Inc

NASDAQ:LAB 4:00:00 PM EDT

2.42

-0.14 (-5.47%)

7:47:09 PM EDT: $2.48 +0.06 (+2.48%)

Market Cap (Intraday)	926.97M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$46.7 Million
Adjusted EPS	-$0.12

See more estimates

10-Day MA	$2.59
50-Day MA	$2.60
200-Day MA	$2.42

See more pivots

Standard BioTools Inc Stock, NASDAQ:LAB

2 Tower Place, Suite 2000, South San Francisco, California 94080

United States of America

Phone: +1.650.266.6000

Number of Employees: 539

http://www.standardbio.com

Description

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.